STOCK TITAN

Vivos Inc to Present at The LD 500 Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

LOS ANGELES, CA / ACCESSWIRE / September 1, 2020 / Vivos Inc (OTCQB:RDGL), a company that has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals and in humans, today announced that it will be presenting at the LD 500 investor conference on Thursday September 3 at 1:40 PST / 4:00 PM EST. Dr. Mike Korenko (CEO of Vivos Inc) will be presenting to a live virtual audience.

Register here: https://ld500.ldmicro.com/

"We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space." stated Chris Lahiji, Founder of LD.

The LD 500 will take place on September 1st through the 4th.

View Vivos Inc's profile here: http://www.RadioGel.com

Profiles powered by LD Micro - News Compliments of Accesswire

About Vivos Inc

Vivos Inc. has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals (Isopet®) and in humans (Radiogel™) that delivers highly localized radiation to destroy cancerous tumors by placing the cancer killing isotope directly inside the treatment area using the company's proprietary hydrogel technology. The injection delivers therapeutic radiation from within the tumor, without the side effects of treatment that characterize external-beam radiation therapy. Vivos maintains domestic and international trademark and patent protection for Isopet® and Radiogel™.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.

What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:

Name: Dr. Mike Korenko
Phone: 509 551 9281
Address: 719 Jadwin Ave; Richland WA 99352
Email:
mkorenko@RadioGel.com

SOURCE: Vivos Inc via LD Micro



View source version on accesswire.com:
https://www.accesswire.com/604184/Vivos-Inc-to-Present-at-The-LD-500-Virtual-Conference

Vivos Inc

OTC:RDGL

RDGL Rankings

RDGL Latest News

RDGL Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Medical Specialties, Health Technology, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Richland

About RDGL

advanced medical isotope corporation (amic) is a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications. amic's focus is on transitioning to full operations upon receipt of expected fda clearance for its patented brachytherapy cancer product, yttrium-90 radiogel™. amic intends to file fda premarket notifications for two related yttrium-90 brachytherapy products. brachytherapy uses radiation to destroy cancerous tumors by placing a radioactive isotope inside or next to the treatment area. annual sales of brachytherapy products exceed $1 billion, about half of which are in the united states. the company intends to outsource material aspects of manufacturing, distribution, sales and marketing for its products in the united states and to enter into licensing arrangements outside of the united states, though the company will evaluate its alternatives before finalizing its plans.